RxDoctor Payments Data

Cameron Barton, MD

Adult Reconstructive Orthopaedic Surgery · Chicago, ILNPI 1962851931

Payments from drug & device makers

What this record shows

This record is dominated by education: $10,101 of the $13,412 with a category attached, or 75.3%. Smith+Nephew accounts for 75.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $7,347 and has fallen 97.0% since, to $218 in 2024. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in IL, where the typical reported total is $12,024.

$13,412in general payments, 2019–2025

Across 29 payments — averaging $462.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$10K
  • Encore Medical, LP$2K
  • Stryker$657
  • Zimmer Biomet$269
  • Biomerieux Inc$210
  • Johnson & Johnson$207
  • plus $281 from 2 others

What the payments were for

  • Consulting fees$2102%
  • Speaking & faculty fees$1,50011%
  • Travel & lodging$180%
  • Food & beverage$1,58212%
  • Education$10,10175%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,412 in reported general payments places this provider in the 50th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.

See all adult reconstructive orthopaedic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$286,171
Medicare patients
415
Services billed
8,479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib22$295
Methocarbamol26$117
Meloxicam30$69

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →